No Detail Found!

Obesity related lung complications and a possible phytochemical therapeutic solution

Author(s)
Sundus Khawaja Department of Biotechnology, University of Azad Jammu and Kashmir, Muzafarabad, Pakistan
Abdul Rehman Khan Department of Chemistry, University of Azad Jammu and Kashmir, Muzaffarabad, Pakistan
Fazli Rabbi Awan Diabetes and Cardio-Metabolic Disorders Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan
Jamshed Iqbal Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan
Abstract
Proteases, especially neutrophil elastase (NE), enzyme provide innate immunity in the lung tissues against elastin protein disintegration by microbial attacks. Normally, an antiprotease, called alpha-1-antitrypsin (A1AT), is responsible to keep NE activity in normal range. In most of the leptin-resistant obese subjects, A1AT deficiency develops which leads to a concurrent higher activity of NE. Obesity associated antiprotease-protease imbalance induces various lung complications, i.e. asthma, emphysema, chronic obstructive pulmonary disorders (COPD), cancer, etc. Past studies manifested that plant extracts/compounds reduce human NE activity. This knowledge will help in future to exploit phytochemicals as interventional therapeutic agents to decrease NE overactivity in susceptible obese individuals. Furthermore, the hypothesis discussed in this article will be helpful for researchers working in the fields of lung biology and obesity.
Publication Details
Page(s) 1616-1618
Published Journal: Journal of Pakistan Medical Association, Volume: 70, Issue: 9, Year: 2020

Request the full text from PASTIC

Keywords
Phytochemicals, Obesity, lung complications
0

Citations

0

Downloads

126

Views